image: A schematic showing how engineered bacteria (yellow) controllably release anti-PD-L1 and antiCTLA-4 nanobodies within tumors. This material relates to a paper that appeared in the Feb. 12, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by C.R. Gurbatri at Columbia University in New York, NY; and colleagues was titled, "Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies." view more
Credit: [Credit: C.R. Gurbatri et al., Science Translational Medicine (2020)]